Viewing nowNeurosartan Tablets 100mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

MFDS item code 201904187 · Approved 2019.06.14
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medicine is used for the treatment of hypertension, particularly effective for patients with type 2 diabetes complicated by hypertension-related kidney disease. It helps protect kidney function and reduce the occurrence of complications by controlling blood pressure. Therefore, it aids in the management of both blood pressure and kidney health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be administered orally in 2 divided doses daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect was observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin or commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations Older adults No adjustment of the initial dose is necessary in older adults aged 75 or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to certain patients, such as those allergic to this medication or its components, women who are pregnant or may become pregnant, patients with severe liver dysfunction, those with hereditary angioedema, patients with primary hyperaldosteronism, or those with lactose intolerance. Additionally, elderly patients, patients with hyperkalemia, patients with mild to moderate liver dysfunction, patients with valvular heart disease, patients with reduced blood volume, and those with compromised kidney function should take this medication with caution. During treatment, various adverse reactions may occur. Common symptoms include dizziness, muscle cramps, back pain, upper respiratory infections, etc., and rarely, serious events such as angioedema, liver dysfunction, or renal failure may occur. Blood pressure and kidney function should be regularly monitored, especially during initial dosing, as there is a risk of too low blood pressure or worsening kidney function. This medication may interact with other drugs. Caution is required when used in conjunction with potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs, lithium, etc. Pregnant or breastfeeding women should avoid this medication; if it must be taken, breastfeeding should be discontinued. This drug is not to be used in children under 6 years old or in children with severe renal impairment. In cases of overdose, hypotension and tachycardia may occur, requiring immediate treatment. Patients planning for pregnancy or who confirm pregnancy during treatment should consult a doctor, and should avoid taking potassium supplements or potassium-containing salt substitutes without consulting a healthcare professional. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and light, preferably at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.
White, drop-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.